标题:在32个欧洲国家评估膀癌的经济负担,使用统计寿命年框架的值
相关实验视频
Updated: Mar 2, 2026
08:39
Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
5.5K
Goran Bencina1, Renato Aste Ruiz2, Boris Bencina1
1University of Zagreb, Croatia.
Journal of cancer policy
|February 28, 2026
概括
膀癌死亡率在2024年使欧洲花费285亿欧元,使用统计寿命年 (VSLY) 方法的价值. 这突显了重要的社会经济影响,为癌症优先事项的医疗保健资源分配提供了信息.
科学领域:
- 卫生经济学 卫生经济学
- 在瘤学瘤学.
- 公共卫生 公共卫生
背景情况:
- 膀癌在欧洲是一个重大的健康问题,诊断通常发生在73岁.
- 膀癌治疗的进步增加了成本,需要基于价值的医疗保健决策的经济证据.
- 传统的疾病成本研究是有限的; 统计生活价值 (VSL) 框架提供了更广泛的经济视角.
研究的目的:
- 为了估计32个欧洲国家的膀癌死亡率的经济负担.
- 使用统计寿命年值 (VSLY) 方法来进行全面的经济评估.
- 提供数据支持基于价值的决策在膀癌管理.
主要方法:
- 关于按年龄分类的膀癌死亡率的数据来源于欧盟统计局对32个欧洲国家的数据.
- 失去了生命年数 (YLL) 用死亡率数据计算.
- 应用了VSLY方法,结合了预期寿命和平均年龄,以量化YLL的经济影响.
主要成果:
- 根据VSLY的估计,2024年膀癌死亡率的经济负担在32个欧洲国家为285亿欧元.
- 七个国家 (德国,意大利,法国,英国,西班牙,波兰,荷兰) 每个成本都超过10亿欧元,共同占总成本的70%以上.
- 专注于65岁之前的YLL将估计成本降低到126亿欧元.
结论:
- 膀癌死亡率给欧洲社会带来了巨大的经济负担.
- 这项研究提供了对膀癌影响的关键经济评估.
- 调查结果可以帮助决策者有效地优先考虑医疗保健资源.
相关概念视频
01:21Cancer Survival Analysis
805
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
805
01:20Actuarial Approach
341
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
341
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
503
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
503